117 related articles for article (PubMed ID: 36476133)
21. Foretinib Overcomes Entrectinib Resistance Associated with the
Nishiyama A; Yamada T; Kita K; Wang R; Arai S; Fukuda K; Tanimoto A; Takeuchi S; Tange S; Tajima A; Furuya N; Kinoshita T; Yano S
Clin Cancer Res; 2018 May; 24(10):2357-2369. PubMed ID: 29463555
[No Abstract] [Full Text] [Related]
22. Oncogenic rearrangements of the NTRK1/NGF receptor.
Pierotti MA; Greco A
Cancer Lett; 2006 Jan; 232(1):90-8. PubMed ID: 16242838
[TBL] [Abstract][Full Text] [Related]
23. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
25. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
[TBL] [Abstract][Full Text] [Related]
26. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract][Full Text] [Related]
27. The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.
Ardini E; Bosotti R; Borgia AL; De Ponti C; Somaschini A; Cammarota R; Amboldi N; Raddrizzani L; Milani A; Magnaghi P; Ballinari D; Casero D; Gasparri F; Banfi P; Avanzi N; Saccardo MB; Alzani R; Bandiera T; Felder E; Donati D; Pesenti E; Sartore-Bianchi A; Gambacorta M; Pierotti MA; Siena S; Veronese S; Galvani A; Isacchi A
Mol Oncol; 2014 Dec; 8(8):1495-507. PubMed ID: 24962792
[TBL] [Abstract][Full Text] [Related]
28. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti MA
Clin Cancer Res; 1998 Jan; 4(1):223-8. PubMed ID: 9516975
[TBL] [Abstract][Full Text] [Related]
29. NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
Rolfo C; Drilon A; Hong D; McCoach C; Dowlati A; Lin JJ; Russo A; Schram AM; Liu SV; Nieva JJ; Nguyen T; Eshaghian S; Morse M; Gettinger S; Mobayed M; Goldberg S; Araujo-Mino E; Vidula N; Bardia A; Subramanian J; Sashital D; Stinchcombe T; Kiedrowski L; Price K; Gandara DR
Br J Cancer; 2022 Feb; 126(3):514-520. PubMed ID: 34480094
[TBL] [Abstract][Full Text] [Related]
30. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR
Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
[TBL] [Abstract][Full Text] [Related]
31. NTRK Gene Fusion Detection in Atypical Spitz Tumors.
Cappellesso R; Nozzoli F; Zito Marino F; Simi S; Castiglione F; De Giorgi V; Cota C; Senetta R; Scognamiglio G; Anniciello AM; Cesinaro AM; Mandalà M; Gianatti A; Valente MG; Valeri B; Sementa AR; Ricci C; Corti B; Roviello G; Dei Tos AP; Franco R; Massi D
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830218
[TBL] [Abstract][Full Text] [Related]
32. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
33. Primary and Metastatic Melanoma With NTRK Fusions.
Lezcano C; Shoushtari AN; Ariyan C; Hollmann TJ; Busam KJ
Am J Surg Pathol; 2018 Aug; 42(8):1052-1058. PubMed ID: 29683819
[TBL] [Abstract][Full Text] [Related]
34. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.
Kim H; Park C; Han KH; Choi J; Kim YB; Kim JK; Park YN
J Hepatol; 2004 Feb; 40(2):298-304. PubMed ID: 14739102
[TBL] [Abstract][Full Text] [Related]
35. Spitz Tumors: Comparison of Histological Features in Relationship to Immunohistochemical Staining for ALK and NTRK1.
Kiuru M; Jungbluth A; Kutzner H; Wiesner T; Busam KJ
Int J Surg Pathol; 2016 May; 24(3):200-6. PubMed ID: 26873340
[TBL] [Abstract][Full Text] [Related]
36. Larotrectinib followed by selitrectinib in a novel
Goh XN; Seng MS; Loh AHP; Gupta A; Chang KTE; Iyer P
J Oncol Pharm Pract; 2021 Mar; 27(2):485-489. PubMed ID: 32693686
[TBL] [Abstract][Full Text] [Related]
37. Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.
Agaram NP; Zhang L; Sung YS; Chen CL; Chung CT; Antonescu CR; Fletcher CD
Am J Surg Pathol; 2016 Oct; 40(10):1407-16. PubMed ID: 27259011
[TBL] [Abstract][Full Text] [Related]
38. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
Tickoo SK; Zee SY; Obiekwe S; Xiao H; Koea J; Robiou C; Blumgart LH; Jarnagin W; Ladanyi M; Klimstra DS
Am J Surg Pathol; 2002 Aug; 26(8):989-97. PubMed ID: 12170085
[TBL] [Abstract][Full Text] [Related]
39. Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
Cook PJ; Thomas R; Kannan R; de Leon ES; Drilon A; Rosenblum MK; Scaltriti M; Benezra R; Ventura A
Nat Commun; 2017 Jul; 8():15987. PubMed ID: 28695888
[TBL] [Abstract][Full Text] [Related]
40. Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification.
Hempel D; Wieland T; Solfrank B; Grossmann V; Steinhard J; Frick A; Hempel L; Eberl T; Gaumann A
Oncologist; 2020 Jun; 25(6):e881-e886. PubMed ID: 32323889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
